AI Article Synopsis

  • Parathyroid carcinoma is extremely rare, especially in patients with tertiary hyperparathyroidism, with only 24 documented cases.
  • A case study details a 51-year-old man with end-stage renal disease who presented with elevated calcium and parathyroid hormone levels; imaging indicated a mass in the right inferior parathyroid gland, leading to a diagnosis of tertiary hyperparathyroidism.
  • Post-surgery, histopathological examination confirmed the mass as parathyroid carcinoma, highlighting the challenges in diagnosing this condition, as it often requires surgical intervention to determine the presence of cancer.

Article Abstract

Introduction: Parathyroid carcinoma is one of the rarest cancers in normal population, and it is extremely uncommon in the setting of tertiary hyperparathyroidism. Indeed, only 24 cases have been reported in the literature. . We report the case of parathyroid carcinoma in a 51-year-old man, with a history of end-stage renal disease due to a horseshoe kidney treated with haemodialysis since 2013. He came to our attention due to an increase in calcium and parathyroid hormone serum levels. Neck ultrasound (US) showed a solid hypodense mass, probably the right inferior parathyroid gland, with an estimated size of 25 × 15 × 13 mm; the 99mTc-sestamibi SPECT/CT scan revealed a large radiotracer activity area in the right cervical region, compatible with a hyperfunctioning right inferior parathyroid gland. So, a tertiary hyperparathyroidism diagnosis was made. In April 2018, resection of three parathyroid glands was performed. Histopathological examination demonstrated the right inferior parathyroid gland specimen to be a parathyroid carcinoma, due to the presence of multiple, full-thickness, capsular infiltration foci, and a venous vascular invasion focus. . Diagnosis of parathyroid carcinoma in tertiary hyperparathyroidism is remarkably complex because of the lack of clinical diagnostic criteria and, in many cases, is made postoperatively at histopathological examination.

Conclusion: To date, radical surgery represents the mainstay of treatment, with a five- and ten-year survival rates overall acceptable.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725582PMC
http://dx.doi.org/10.1155/2020/5710468DOI Listing

Publication Analysis

Top Keywords

parathyroid carcinoma
20
tertiary hyperparathyroidism
16
inferior parathyroid
12
parathyroid gland
12
parathyroid
10
setting tertiary
8
carcinoma setting
4
tertiary
4
hyperparathyroidism
4
hyperparathyroidism case
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!